Back to User profile » Dr Ming-Ju Tsai
Paper published by Dr Ming-Ju Tsai:
Original Research
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Yang CJ, Tsai MJ, Hung JY, Liu TC, Chou SH, Lee JY, Hsu JS, Tsai YM, Huang MS, Chong IW
OncoTargets and Therapy 2016, 9:1579-1587
Published Date: 16 March 2016